Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
Raza A, Khan AQ, Inchakalody VP, Mestiri S, Yoosuf ZSKM, Bedhiafi T, El-Ella DMA, Taib N, Hydrose S, Akbar S, Fernandes Q, Al-Zaidan L, Krishnankutty R, Merhi M, Uddin S, Dermime S. Raza A, et al. Among authors: akbar s. J Exp Clin Cancer Res. 2022 Mar 15;41(1):99. doi: 10.1186/s13046-022-02318-0. J Exp Clin Cancer Res. 2022. PMID: 35292091 Free PMC article. Review.
Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Akbar S, Raza A, Mohsin R, Kanbour A, Qadri S, Parray A, Zar Gul AR, Philip A, Vijayakumar S, Merhi M, Hydrose S, Inchakalody VP, Al-Abdulla R, Abualainin W, Sirriya SA, Al-Bozom I, Uddin S, Khan OM, Mohamed Ibrahim MI, Al Homsi U, Dermime S. Akbar S, et al. Front Immunol. 2023 Jan 18;13:1097117. doi: 10.3389/fimmu.2022.1097117. eCollection 2022. Front Immunol. 2023. PMID: 36741391 Free PMC article.
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression.
Raza A, Mohsen R, Kanbour A, Zar Gul AR, Philip A, Vijayakumar S, Hydrose S, Prabhu KS, Al-Suwaidi AK, Inchakalody VP, Merhi M, Abo El-Ella DM, Tauro MA, Akbar S, Al-Bozom I, Abualainin W, Al-Abdulla R, Sirriya SA, Hassnad S, Uddin S, Mohamed Ibrahim MI, Al Homsi U, Demime S. Raza A, et al. Among authors: akbar s. Front Immunol. 2023 May 15;14:1157100. doi: 10.3389/fimmu.2023.1157100. eCollection 2023. Front Immunol. 2023. PMID: 37256148 Free PMC article.
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.
Mestiri S, El-Ella DMA, Fernandes Q, Bedhiafi T, Almoghrabi S, Akbar S, Inchakalody V, Assami L, Anwar S, Uddin S, Gul ARZ, Al-Muftah M, Merhi M, Raza A, Dermime S. Mestiri S, et al. Among authors: akbar s. Biomed Pharmacother. 2024 Feb;171:116095. doi: 10.1016/j.biopha.2023.116095. Epub 2024 Jan 6. Biomed Pharmacother. 2024. PMID: 38183744 Free article. Review.
Early Detection of Novel SARS-CoV-2 Variants from Urban and Rural Wastewater through Genome Sequencing and Machine Learning.
Zhuang X, Vo V, Moshi MA, Dhede K, Ghani N, Akbar S, Chang CL, Young AK, Buttery E, Bendik W, Zhang H, Afzal S, Moser D, Cordes D, Lockett C, Gerrity D, Kan HY, Oh EC. Zhuang X, et al. Among authors: akbar s. medRxiv [Preprint]. 2024 Apr 19:2024.04.18.24306052. doi: 10.1101/2024.04.18.24306052. medRxiv. 2024. PMID: 38699326 Free PMC article. Preprint.
619 results